Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 2/20 | 0.47 |
| ▸ | FDPS | P14324 | 2/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.43 |
| ▸ | RRM1 | P23921 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9452883 | 1.00 | SMPD1 (0.47) | SMPD1FDPSEPHX1RRM1CES2 | |
| SCHEMBL31107113 | 0.94 | DNM1 (0.46) | SMPD1FDPSEPHX1CES2DNM1 | |
| SCHEMBL18641723 | 0.94 | FDPS (0.47) | SMPD1FDPSCES2 | |
| SCHEMBL10896548 | 0.94 | FDPS (0.47) | SMPD1FDPSCES2 | |
| SCHEMBL29180319 | 0.94 | FDPS (0.47) | SMPD1FDPSCES2 | |
| SCHEMBL31472765 | 0.94 | FDPS (0.47) | SMPD1FDPSCES2 | |
| SCHEMBL28052087 | 0.94 | FDPS (0.47) | SMPD1FDPSCES2 | |
| SCHEMBL20510878 | 0.94 | FDPS (0.47) | SMPD1FDPSCES2 | |
| SCHEMBL20954037 | 0.94 | FDPS (0.47) | SMPD1FDPSCES2 | |
| SCHEMBL28100654 | 0.94 | FDPS (0.47) | SMPD1FDPSCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584241-A2 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | Acuitas Therapeutics, Inc. (CA) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054843-A2 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | Acuitas Therapeutics, Inc. (CA) | 2024-03-14 | — | — | WO | disclosed |